Literature DB >> 22846677

miR-203 regulates nociceptive sensitization after incision by controlling phospholipase A2 activating protein expression.

Yuan Sun1, Xiang-Qi Li, Peyman Sahbaie, Xiao-You Shi, Wen-Wu Li, De-Yong Liang, J David Clark.   

Abstract

BACKGROUND: After incision keratinocytes in the epidermis become activated to produce a range of pain-related mediators. microRNA 203 (miR-203) is known to be involved in keratinocyte growth, differentiation, and skin inflammation. We hypothesized that one or more of these mediators might be under the control of miR-203.
METHODS: The expression of miR-203 and its target gene, phospholipase A2 activating protein (PLAA), were examined after hind paw incision in mice. We investigated the local effect of intraplantar PLAA peptide injection in normal mice and the effects of a selective secretory phospholipase A2 inhibitor (HK064) on PLAA or incision-induced mechanical allodynia. Last, we investigated the role of substance P signaling in regulating miR-203 and PLAA expression in vitro and in vivo.
RESULTS: Levels of miR-203 were strongly down-regulated in keratinocytes after incision. Informatics-based approaches identified PLAA as a likely candidate for regulation by miR-203. PLAA caused mechanical allodynia and conditioned place aversion but not thermal sensitization. HK064 reduced mechanical allodynia after incision and after intraplantar injection of PLAA. Using preprotachykinin gene knockout mice or with neurokinin-1 selective antagonist LY303870 treatment, we observed that substance P-mediated signaling was also required for miR-203 and PLAA regulation after incision. Finally, using the rat epidermal keratinocyte cell line, we observed that a miR-203 mimic molecule could block the substance P-induced increase in PLAA expression observed under control conditions.
CONCLUSIONS: miR-203 may regulate expression of the novel nociceptive mediator PLAA after incision. Furthermore, the regulation of miR-203 and PLAA levels is reliant upon intact substance P signaling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22846677      PMCID: PMC3430388          DOI: 10.1097/ALN.0b013e31826571aa

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  74 in total

1.  Profilaggrin requires both linker and filaggrin peptide sequences to form granules: implications for profilaggrin processing in vivo.

Authors:  M K Kuechle; C D Thulin; R B Presland; B A Dale
Journal:  J Invest Dermatol       Date:  1999-06       Impact factor: 8.551

2.  A skin microRNA promotes differentiation by repressing 'stemness'.

Authors:  Rui Yi; Matthew N Poy; Markus Stoffel; Elaine Fuchs
Journal:  Nature       Date:  2008-03-02       Impact factor: 49.962

3.  Sciatic nerve injury induces functional pro-nociceptive chemokine receptors in bladder-associated primary afferent neurons in the rat.

Authors:  R Foster; J Jung; A Farooq; C McClung; M S Ripsch; M P Fitzgerald; F A White
Journal:  Neuroscience       Date:  2011-03-30       Impact factor: 3.590

4.  MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma.

Authors:  B P L Wijnhoven; D J Hussey; D I Watson; A Tsykin; C M Smith; M Z Michael
Journal:  Br J Surg       Date:  2010-06       Impact factor: 6.939

5.  Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.

Authors:  M Inoue; W Xie; Y Matsushita; J Chun; J Aoki; H Ueda
Journal:  Neuroscience       Date:  2008-01-09       Impact factor: 3.590

6.  Snake venom phospholipase A2s (Asp49 and Lys49) induce mechanical allodynia upon peri-sciatic administration: involvement of spinal cord glia, proinflammatory cytokines and nitric oxide.

Authors:  Marucia Chacur; Erin D Milligan; Evan M Sloan; Julie Wieseler-Frank; Ruth M Barrientos; David Martin; Stephen Poole; Brono Lomonte; Jose Maria Gutiérrez; Steven F Maier; Yara Cury; Linda R Watkins
Journal:  Pain       Date:  2004-03       Impact factor: 6.961

7.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

8.  miR-203 represses 'stemness' by repressing DeltaNp63.

Authors:  A M Lena; R Shalom-Feuerstein; P Rivetti di Val Cervo; D Aberdam; R A Knight; G Melino; E Candi
Journal:  Cell Death Differ       Date:  2008-05-16       Impact factor: 15.828

9.  The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome.

Authors:  Wen-Wu Li; Tian-Zhi Guo; Deyong Liang; Xiaoyou Shi; Tzuping Wei; Wade S Kingery; J David Clark
Journal:  Pain       Date:  2009-10-22       Impact factor: 6.961

10.  Dynamic changes in the microRNA expression profile reveal multiple regulatory mechanisms in the spinal nerve ligation model of neuropathic pain.

Authors:  David von Schack; Michael J Agostino; B Stuart Murray; Yizheng Li; Padmalatha S Reddy; Jin Chen; Sung E Choe; Brian W Strassle; Christine Li; Brian Bates; Lynn Zhang; Huijuan Hu; Smita Kotnis; Brendan Bingham; Wei Liu; Garth T Whiteside; Tarek A Samad; Jeffrey D Kennedy; Seena K Ajit
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

View more
  22 in total

1.  Computational functional genomics based analysis of pain-relevant micro-RNAs.

Authors:  Jörn Lötsch; Ellen Niederberger; Alfred Ultsch
Journal:  Hum Genet       Date:  2015-09-18       Impact factor: 4.132

2.  Quantification of the differential expression levels of microRNA-203 in different degrees of diabetic foot.

Authors:  Jian Liu; Yingbin Xu; Bin Shu; Peng Wang; Jinming Tang; Lei Chen; Shaohai Qi; Xusheng Liu; Julin Xie
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  MicroRNA-1224 Splicing CircularRNA-Filip1l in an Ago2-Dependent Manner Regulates Chronic Inflammatory Pain via Targeting Ubr5.

Authors:  Zhiqiang Pan; Guo-Fang Li; Meng-Lan Sun; Ling Xie; Di Liu; Qi Zhang; Xiao-Xiao Yang; Sunhui Xia; Xiaodan Liu; Huimin Zhou; Zhou-Ya Xue; Ming Zhang; Ling-Yun Hao; Li-Jiao Zhu; Jun-Li Cao
Journal:  J Neurosci       Date:  2019-01-16       Impact factor: 6.167

4.  Sex differences in a Murine Model of Complex Regional Pain Syndrome.

Authors:  Maral Tajerian; Peyman Sahbaie; Yuan Sun; David Leu; Hsun Yu Yang; Wenwu Li; Ting Ting Huang; Wade Kingery; J David Clark
Journal:  Neurobiol Learn Mem       Date:  2015-06-09       Impact factor: 2.877

5.  miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice.

Authors:  Ping Jia; Jie Teng; Jianzhou Zou; Yi Fang; Xiaoyan Zhang; Zeljko J Bosnjak; Mingyu Liang; Xiaoqiang Ding
Journal:  Anesthesiology       Date:  2013-09       Impact factor: 7.892

Review 6.  Epigenetic regulation of persistent pain.

Authors:  Guang Bai; Ke Ren; Ronald Dubner
Journal:  Transl Res       Date:  2014-05-29       Impact factor: 7.012

7.  Opioids enhance CXCL1 expression and function after incision in mice.

Authors:  Yuan Sun; Peyman Sahbaie; DeYong Liang; Wenwu Li; J David Clark
Journal:  J Pain       Date:  2014-06-02       Impact factor: 5.820

8.  Optimizing Perioperative Use of Opioids: A Multimodal Approach.

Authors:  Maria F Ramirez; Brinda B Kamdar; Juan P Cata
Journal:  Curr Anesthesiol Rep       Date:  2020-09-07

Review 9.  microRNAs in nociceptive circuits as predictors of future clinical applications.

Authors:  Michaela Kress; Alexander Hüttenhofer; Marc Landry; Rohini Kuner; Alexandre Favereaux; David Greenberg; Josef Bednarik; Paul Heppenstall; Florian Kronenberg; Marzia Malcangio; Heike Rittner; Nurcan Uçeyler; Zlatko Trajanoski; Peter Mouritzen; Frank Birklein; Claudia Sommer; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2013-10-17       Impact factor: 5.639

10.  Identification of a novel substance P (SP)-neurokinin-1 receptor (NK-1R) microRNA-221-5p inflammatory network in human colonic epithelial cells.

Authors:  Kai Fang; Aristea Sideri; Ivy Ka Man Law; Kyriaki Bakirtzi; Christos Polytarchou; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.